These final results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the idea of targeting ACKR3 as a novel approach to modulate the opioid method, which could open new therapeutic avenues for opioid-associated Issues. Disclaimer: The above mentioned is https://josepho369spj8.vblogetin.com/profile